In fact, two key TGF-β pathway genes, TGFB1, a TGF-β ligand, and TGFBR2, a TGF-β receptor, were found to have increased expression in tumor samples of non-responders, and to be associated with reduced OS. Here, TGFB1 is linked to neoplasm.